- Home
- TTNP vs SCNI Comparison
TTNP vs SCNI Comparison
Compare TTNP & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- SCNI
- Stock Information
- Founded
- TTNP 1991
- SCNI 2003
- Country
- TTNP United States
- SCNI Israel
- Employees
- TTNP N/A
- SCNI N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TTNP Health Care
- SCNI Health Care
- Exchange
- TTNP Nasdaq
- SCNI Nasdaq
- Market Cap
- TTNP 3.4M
- SCNI 2.8M
- IPO Year
- TTNP 1996
- SCNI N/A
- Fundamental
- Price
- TTNP $3.66
- SCNI $2.53
- Analyst Decision
- TTNP
- SCNI
- Analyst Count
- TTNP 0
- SCNI 0
- Target Price
- TTNP N/A
- SCNI N/A
- AVG Volume (30 Days)
- TTNP 33.4K
- SCNI 11.5K
- Earning Date
- TTNP 05-14-2025
- SCNI 05-14-2025
- Dividend Yield
- TTNP N/A
- SCNI N/A
- EPS Growth
- TTNP N/A
- SCNI N/A
- EPS
- TTNP N/A
- SCNI 8.20
- Revenue
- TTNP N/A
- SCNI $452,000.00
- Revenue This Year
- TTNP N/A
- SCNI N/A
- Revenue Next Year
- TTNP N/A
- SCNI N/A
- P/E Ratio
- TTNP N/A
- SCNI $0.33
- Revenue Growth
- TTNP N/A
- SCNI N/A
- 52 Week Low
- TTNP $3.03
- SCNI $2.23
- 52 Week High
- TTNP $14.80
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- TTNP 48.06
- SCNI 27.28
- Support Level
- TTNP $3.48
- SCNI $2.64
- Resistance Level
- TTNP $4.15
- SCNI $2.86
- Average True Range (ATR)
- TTNP 0.36
- SCNI 0.28
- MACD
- TTNP 0.00
- SCNI -0.07
- Stochastic Oscillator
- TTNP 24.37
- SCNI 16.77
Stock Price Comparison Chart: TTNP vs SCNI
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.